The Deal Register
Database › Equity financing › ZYUS Life Sciences Announces Closing of Second Tranche of Unit…

Equity financing

ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

Lane
Equity financing
Announced
15 Aug 2025
Province
Saskatchewan
Industry
Healthcare & life sciences
Status
Announced
What the filing says
ZYUS Life Sciences Corporation (the " Company ") (TSXV: ZYUS ), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche ") of its non-brokered private placement (the " Offering ") of units of the Company (each a " Unit ") for up to CAD $1,000,000 .
Terms stated
price per security
Releases (2)
  • 29 Jul 2025 — ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering
  • 15 Aug 2025 — ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
Source

The terms are in the subscriber edition

This transaction carries 1 stated term, with its value, unit and basis and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe